Skip to main content
Livermore
Livermore
ZHEN

Reata Pharmaceuticals Inc

RETADelisted Sep 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001358762

Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Reata Pharmaceuticals Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of RETA: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1832151−30
Shares26.7M77126.7M+22.9K (+0.1%)
Value$2.69B$78.0K$704.3M−$1.98B (−73.8%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Reata Pharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to RETA in Q4 2021
InstitutionSharesValue% of portfolio
Opaleye Management Inc.330,000$8.70M1.85%
Voloridge Investment Management, LLC322,586$8.51M0.05%
Healthcare of Ontario Pension Plan Trust Fund260,300$6.86M0.01%
Assenagon Asset Management S.A.172,323$4.54M0.02%
Canada Pension Plan Investment Board156,000$4.11M0.00%
Balyasny Asset Management LLC144,521$3.81M0.02%
Duality Advisers, LP123,844$3.27M0.35%
Two Sigma Investments, LP102,002$2.69M0.01%
Caption Management, LLC99,900$2.63M0.16%
ExodusPoint Capital Management, LP65,558$1.73M0.02%
Ghost Tree Capital, LLC55,000$1.45M0.56%
Walleye Capital LLC51,036$1.35M0.04%
D. E. Shaw & Co., Inc.48,129$1.27M0.00%
Long Focus Capital Management, LLC48,000$1.27M0.35%
Ergoteles LLC45,955$1.21M0.05%
Twinbeech Capital LP45,203$1.19M0.07%
Simplex Trading, LLC37,150$979.0K0.03%
KRS Capital Management, LLC32,841$866.0K0.74%
Highlander Partners, L.P.27,600$728.0K0.89%
Engineers Gate Manager LP25,128$663.0K0.03%
Qube Research & Technologies Ltd17,810$470.0K0.00%
Capital Fund Management S.A.14,453$381.1K0.01%
NinePointTwo Capital10,799$284.0K0.09%
Campbell & CO Investment Adviser LLC9,400$248.0K0.08%
Walleye Trading LLC6,965$184.0K0.00%
Ensign Peak Advisors, Inc6,580$174.0K0.00%
Allspring Global Investments Holdings, LLC3,693$97.0K0.00%
Spire Wealth Management500$13.0K0.00%
Allworth Financial LP109$3.00K0.00%
Washington Trust Advisors, Inc.58$2.00K0.00%
Adirondack Trust Co55$1.00K0.00%
Missouri Trust & Investment Co20$1.00K0.00%
Financial Perspectives, Inc10$2640.00%
CWM, LLC14$00.00%

Sold out (64)

Institutions that held Reata Pharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of RETA in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Camber Capital Management LP685,000$68.9M
Sofinnova Investments, Inc.157,488$15.8M
Rice Hall James & Associates, LLC114,806$11.6M
Biondo Investment Advisors, LLC104,120$10.5M
Cormorant Asset Management, LP100,000$10.1M
Pictet Asset Management SA98,616$9.92M
Paragon Associates & Paragon Associates II Joint Venture46,646$4.69M
Thrivent Financial for Lutherans39,135$3.94M
WCM Investment Management, LLC26,997$2.72M
Jump Financial, LLC22,500$2.26M
Acuta Capital Partners, LLC17,500$1.76M
Adage Capital Partners GP, L.L.C.17,000$1.71M
Serengeti Asset Management LP15,000$1.51M
Am Investment Strategies LLC12,465$1.25M
Principal Financial Group Inc11,622$1.17M
Lazard Asset Management LLC11,338$1.14M
Keybank National Association10,000$1.01M
Man Group plc9,235$930.0K
SEI Investments Co7,241$746.0K
Arizona State Retirement System7,263$731.0K
Hellman Jordan Management Co Inc6,708$675.0K
Sigma Planning Corp6,544$658.0K
ACT Capital Management, LLC6,000$604.0K
Handelsbanken Fonder AB5,900$594.0K
Crestline Management, LP5,909$594.0K
Susquehanna International Group, LLP5,096$513.0K
Quattro Financial Advisors LLC5,000$496.0K
Transcend Wealth Collective, LLC5,000$485.0K
Amalgamated Bank4,715$474.0K
Teacher Retirement System of Texas4,247$427.0K
Laurel Wealth Advisors, Inc.4,217$424.0K
M&T Bank Corp4,120$415.0K
First Trust Advisors LP3,946$397.0K
Susquehanna Fundamental Investments, LLC3,680$370.0K
Silvant Capital Management LLC3,483$350.0K
Johnson Investment Counsel Inc3,469$349.0K
Vivid Financial Management, Inc.3,176$320.0K
Ameriprise Financial Inc3,015$304.0K
Inscription Capital, LLC3,000$302.0K
Envestnet Asset Management Inc2,626$264.0K
Penn Davis McFarland Inc2,565$258.0K
Profund Advisors LLC2,532$255.0K
GM Advisory Group, Inc.2,464$248.0K
Raymond James Financial Services Advisors, Inc.2,458$247.0K
Cambridge Investment Research Advisors, Inc.2,388$240.0K
Prudential Financial Inc2,365$238.0K
Los Angeles Capital Management LLC2,257$227.0K
First Republic Investment Management, Inc.2,247$226.0K
Mairs & Power Inc2,000$201.0K
STRS Ohio1,400$140.0K
Sofos Investments, Inc.0$101.0K
Penserra Capital Management LLC720$72.0K
O'Shaughnessy Asset Management, LLC646$65.0K
Point72 Hong Kong Ltd414$42.0K
Stonehage Fleming Financial Services Holdings Ltd350$35.0K
Glassman Wealth Services65$7.00K
Signaturefd, LLC35$4.00K
Lindbrook Capital, LLC26$3.00K
Bellevue Asset Management, LLC29$3.00K
JFS Wealth Advisors, LLC24$2.00K
Meeder Asset Management Inc11$1.00K
Parkside Financial Bank & Trust9$1.00K
Northwestern Mutual Wealth Management Co4$0
Meridian Wealth Partners, LLC2$0

Not filed for Q4 2021 yet (2)

Institutions that held Reata Pharmaceuticals Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RETA in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
First Mercantile Trust Co721$73.0K
Berman Capital Advisors, LLC50$5.00K